Veraxa Biotech Holding AG VRXAW
NASDAQ VRXAW
$0.08 -0.01 (-7.89%)
At close: Aug 18, 2026 · 9:30 AM UTC

Veraxa Biotech Holding AG (VRXAW) Liabilities and Shareholders Equity (2024 - 2025)

Veraxa Biotech Holding AG (VRXAW) posted quarterly Liabilities and Shareholders Equity of $101.1 million for Q4 2025, up 4.5% year-over-year from $96.8 million in Q4 2024, and up 4.5% quarter-over-quarter from $96.8 million in Q4 2024.

Veraxa Biotech Holding AG (VRXAW) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends

Veraxa Biotech Holding AG (VRXAW) has reported Liabilities and Shareholders Equity for 2 consecutive years, with $101.1 million the latest figure, recorded in Q4 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 101.12 Mn
Dec 31, 2024 96.76 Mn